Home › Breast Cancer › Nevada › Reno
Breast Cancer clinical trials in Reno, NV
13 studies for Breast Cancer are looking for participants at sites in and around Reno (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
RecruitingPhase 3
- Cancer Care Specialists, Reno
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecruitingObservational studyHealthy volunteers welcome
- Renown Regional Medical Center, Reno
- Saint Mary's Regional Medical Center, Reno
- Carson Tahoe Regional Medical Center, Carson City · 25 mi away
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
RecruitingPhase 2
- Cancer Care Specialists, Reno
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
RecruitingPhase 3
- Renown Regional Medical Center ( Site 0041), Reno
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer
RecruitingPhase 1/2
- Renown Regional Medical Center, Reno
A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer
RecruitingPhase 3
- Research Site, Reno
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
RecruitingPhase 3
- Renown Health Medical Oncology, Reno
Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies
RecruitingObservational study
- Cancer Care Specialist of Reno, Reno
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
RecruitingPhase 3
- Renown Regional Medical Center, Reno
- Saint Mary's Regional Medical Center, Reno
- Gene Upshaw Memorial Tahoe Forest Cancer Center, Truckee · 24 mi away
- and 1 more
E-Mindfulness Approaches for Living After Breast Cancer
RecruitingPhase 3
- Gene Upshaw Memorial Tahoe Forest Cancer Center, Truckee · 24 mi away
Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
RecruitingPhase 3
- Renown Regional Medical Centre, Reno
- Cancer Care Specialists, Reno
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
RecruitingPhase 3
- Renown Regional Medical Center, Reno
- Gene Upshaw Memorial Tahoe Forest Cancer Center, Truckee · 24 mi away
First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer
RecruitingPhase 1
- Renown Regional Medical Center, Reno
About Breast Cancer
Breast cancer is a cancer that starts in the breast tissue, when cells change and grow out of control. These extra cells can form a mass called a tumor.
More about Breast Cancer on MedlinePlus
Breast Cancer trials in other cities
- New York City, NY134 studies
- Houston, TX126 studies
- Boston, MA111 studies
- Nashville, TN80 studies
- Los Angeles, CA72 studies
- Edison, NJ68 studies
- St. Louis, MO64 studies
- Durham, NC63 studies
- Queens, NY63 studies
- Chicago, IL58 studies
- Philadelphia, PA56 studies
- Dallas, TX55 studies
Other studies in Reno
- Non-Small Cell Lung Cancer16 studies
- Lung Cancer9 studies
- Macular Degeneration8 studies
- Geographic Atrophy8 studies
- Ovarian Cancer7 studies
- Cancer (all types)7 studies
- Colorectal Cancer5 studies
- Acute Myeloid Leukemia5 studies
- Metastatic Cancer5 studies
- Pancreatic Cancer5 studies
- Colon Cancer5 studies
- Rectal Cancer4 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.